Proteome Sciences plc (PMSNF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 18.48 Million USD | 15.15% |
| 2022 | 16.05 Million USD | -7.35% |
| 2021 | 17.33 Million USD | 1.82% |
| 2020 | 17.01 Million USD | 6.95% |
| 2019 | 15.91 Million USD | 15.22% |
| 2018 | 13.81 Million GBP | 1.75% |
| 2017 | 13.57 Million GBP | 11.09% |
| 2016 | 12.21 Million GBP | -16.12% |
| 2015 | 14.56 Million GBP | 58.87% |
| 2014 | 9.17 Million GBP | -0.92% |
| 2013 | 9.25 Million GBP | 19.94% |
| 2012 | 7.71 Million GBP | 1.39% |
| 2011 | 7.61 Million GBP | -9.16% |
| 2010 | 8.37 Million GBP | -45.73% |
| 2009 | 15.43 Million GBP | 27.93% |
| 2008 | 12.06 Million GBP | 37.16% |
| 2007 | 8.79 Million GBP | 131.04% |
| 2006 | 3.8 Million GBP | 120.75% |
| 2005 | 1.72 Million GBP | 12.01% |
| 2004 | 1.54 Million GBP | -40.38% |
| 2003 | 2.58 Million GBP | 30.19% |
| 2002 | 1.98 Million GBP | 60.26% |
| 2001 | 1.23 Million GBP | -21.4% |
| 2000 | 1.57 Million GBP | 125.97% |
| 1999 | 697 Thousand GBP | -19.14% |
| 1998 | 862 Thousand GBP | 56.44% |
| 1997 | 551 Thousand GBP | 93.33% |
| 1996 | 285 Thousand GBP | -40.63% |
| 1995 | 480 Thousand GBP | -30.23% |
| 1994 | 688 Thousand GBP | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 18.61 Million USD | 0.0% |
| 2023 Q4 | 18.48 Million USD | 4.34% |
| 2023 Q3 | 17.71 Million GBP | 11.89% |
| 2023 Q1 | 15.39 Million GBP | -4.13% |
| 2023 FY | 18.48 Million USD | 15.15% |
| 2023 Q2 | 15.83 Million USD | 2.89% |
| 2022 Q3 | 14.82 Million GBP | -9.84% |
| 2022 Q2 | 16.44 Million GBP | -7.35% |
| 2022 Q4 | 16.05 Million USD | 8.3% |
| 2022 Q1 | 17.74 Million GBP | 2.41% |
| 2022 FY | 16.05 Million USD | -7.35% |
| 2021 Q3 | 17.27 Million GBP | 0.95% |
| 2021 Q1 | 16.4 Million GBP | -3.61% |
| 2021 FY | 17.33 Million USD | 1.82% |
| 2021 Q4 | 17.33 Million GBP | 0.32% |
| 2021 Q2 | 17.11 Million GBP | 4.32% |
| 2020 Q3 | 16.06 Million GBP | 7.19% |
| 2020 Q1 | 14.52 Million GBP | -8.74% |
| 2020 Q2 | 14.98 Million GBP | 3.2% |
| 2020 Q4 | 17.01 Million GBP | 5.94% |
| 2020 FY | 17.01 Million USD | 6.95% |
| 2019 Q2 | 15.44 Million GBP | 0.69% |
| 2019 FY | 15.91 Million USD | 15.22% |
| 2019 Q1 | 15.33 Million GBP | 41.41% |
| 2019 Q4 | 15.91 Million GBP | 11.48% |
| 2019 Q3 | 14.27 Million GBP | -7.55% |
| 2018 FY | 13.81 Million GBP | 1.75% |
| 2018 Q2 | 10.11 Million GBP | -25.67% |
| 2018 Q1 | 13.6 Million GBP | 35.62% |
| 2018 Q3 | 13.68 Million GBP | 35.3% |
| 2018 Q4 | 10.84 Million GBP | -20.76% |
| 2017 Q4 | 10.03 Million GBP | -22.56% |
| 2017 Q3 | 12.95 Million GBP | 30.96% |
| 2017 Q2 | 9.89 Million GBP | -20.19% |
| 2017 FY | 13.57 Million GBP | 11.09% |
| 2017 Q1 | 12.39 Million GBP | 25.37% |
| 2016 Q1 | 14.43 Million GBP | 46.0% |
| 2016 Q4 | 9.88 Million GBP | -22.86% |
| 2016 Q2 | 10.01 Million GBP | -30.57% |
| 2016 FY | 12.21 Million GBP | -16.12% |
| 2016 Q3 | 12.81 Million GBP | 27.95% |
| 2015 Q4 | 9.88 Million GBP | -33.91% |
| 2015 Q1 | 13.28 Million GBP | 44.86% |
| 2015 FY | 14.56 Million GBP | 58.87% |
| 2015 Q3 | 14.95 Million GBP | 62.41% |
| 2015 Q2 | 9.2 Million GBP | -30.68% |
| 2014 Q3 | 14.36 Million GBP | 54.68% |
| 2014 FY | 9.17 Million GBP | -0.92% |
| 2014 Q2 | 9.28 Million GBP | -38.26% |
| 2014 Q1 | 15.04 Million GBP | 62.56% |
| 2014 Q4 | 9.17 Million GBP | -36.18% |
| 2013 FY | 9.25 Million GBP | 19.94% |
| 2013 Q2 | 9.07 Million GBP | -32.52% |
| 2013 Q1 | 13.44 Million GBP | 74.26% |
| 2013 Q4 | 9.25 Million GBP | -36.48% |
| 2013 Q3 | 14.57 Million GBP | 60.58% |
| 2012 Q4 | 7.71 Million GBP | 0.0% |
| 2012 FY | 7.71 Million GBP | 1.39% |
| 2012 Q2 | 7.65 Million GBP | 0.0% |
| 2011 FY | 7.61 Million GBP | -9.16% |
| 2011 Q4 | 7.61 Million GBP | 0.0% |
| 2011 Q2 | 7.49 Million GBP | 0.0% |
| 2010 Q4 | 8.37 Million GBP | 0.0% |
| 2010 Q2 | 11.4 Million GBP | 0.0% |
| 2010 FY | 8.37 Million GBP | -45.73% |
| 2009 Q2 | 13.8 Million GBP | 0.0% |
| 2009 FY | 15.43 Million GBP | 27.93% |
| 2009 Q4 | 15.43 Million GBP | 0.0% |
| 2008 FY | 12.06 Million GBP | 37.16% |
| 2008 Q4 | 12.06 Million GBP | 0.0% |
| 2008 Q2 | 9.94 Million GBP | 0.0% |
| 2007 Q2 | 6.13 Million GBP | 0.0% |
| 2007 FY | 8.79 Million GBP | 131.04% |
| 2007 Q4 | 8.79 Million GBP | 0.0% |
| 2006 Q4 | 3.8 Million GBP | 0.0% |
| 2006 Q2 | 2.31 Million GBP | 0.0% |
| 2006 FY | 3.8 Million GBP | 120.75% |
| 2005 Q2 | 1.51 Million GBP | 0.0% |
| 2005 Q4 | 1.72 Million GBP | 0.0% |
| 2005 FY | 1.72 Million GBP | 12.01% |
| 2004 Q2 | 2.04 Million GBP | 0.0% |
| 2004 Q4 | 1.54 Million GBP | 0.0% |
| 2004 FY | 1.54 Million GBP | -40.38% |
| 2003 FY | 2.58 Million GBP | 30.19% |
| 2002 FY | 1.98 Million GBP | 60.26% |
| 2001 FY | 1.23 Million GBP | -21.4% |
| 2000 FY | 1.57 Million GBP | 125.97% |
| 1999 FY | 697 Thousand GBP | -19.14% |
| 1998 FY | 862 Thousand GBP | 56.44% |
| 1997 FY | 551 Thousand GBP | 93.33% |
| 1996 FY | 285 Thousand GBP | -40.63% |
| 1995 FY | 480 Thousand GBP | -30.23% |
| 1994 FY | 688 Thousand GBP | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | -412.446% |
| Arrayit Corporation | 7.49 Million USD | -146.633% |
| Atlantic International Corp. | 3.82 Million USD | -382.917% |
| Biocept, Inc. | 22.01 Million USD | 16.008% |
| Bioqual, Inc. | 18.93 Million USD | 2.371% |
| CardioGenics Holdings Inc | 1.79 Million USD | -930.075% |
| DermTech, Inc. | 64.75 Million USD | 71.448% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 97.484% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | -49.274% |
| iMD Companies, Inc. | 1.67 Million USD | -1004.341% |
| IDenta Corp. | 1.01 Million USD | -1724.893% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 34.336% |
| Integrative Health Technologies, Inc. | 297.94 Thousand USD | -6105.484% |
| InVitro International | 78.99 Thousand USD | -23306.826% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 6.285% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -14199.676% |
| Medical Imaging Corp. | 9.51 Million USD | -94.272% |
| NovelStem International Corp. | 4.2 Million USD | -339.579% |
| Optigenex Inc. | 9.57 Million USD | -93.186% |
| PharmChem, Inc. | 558.64 Thousand USD | -3209.613% |
| Response Genetics, Inc | 15.86 Million USD | -16.525% |
| Rennova Health, Inc. | 49.66 Million USD | 62.774% |
| RushNet, Inc. | 6.23 Million USD | -196.347% |
| ScreenPro Security Inc. | 1.6 Million USD | -1055.142% |
| Stella Diagnostics Inc. | 18 Million USD | -2.686% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | -125.367% |
| Todos Medical Ltd. | 50.15 Million USD | 63.138% |